These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

861 related items for PubMed ID: 25400814

  • 1. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, Wang C.
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [Abstract] [Full Text] [Related]

  • 2. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M.
    Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
    [Abstract] [Full Text] [Related]

  • 3. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ, Hu ZX, Li QH, Wang SM, Song CJ, Wu DD, He JL, Guan JC, Shan JP.
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C, Gaede L, Doerr O, Blumenstein J, Rixe J, Teichert O, Willmer M, Weber M, Rolf A, Möllmann H, Hamm C, Nef H.
    Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
    [Abstract] [Full Text] [Related]

  • 5. Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS.
    Stelmach-Goldys A, Czarkowska-Paczek B, Wyczalkowska-Tomasik A, Paczek L.
    Eur J Haematol; 2015 Feb; 94(2):162-8. PubMed ID: 25046079
    [Abstract] [Full Text] [Related]

  • 6. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery.
    Seitz S, Rauh M, Gloeckler M, Cesnjevar R, Dittrich S, Koch AM.
    Swiss Med Wkly; 2013 Feb; 143():w13744. PubMed ID: 23348800
    [Abstract] [Full Text] [Related]

  • 7. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG.
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [Abstract] [Full Text] [Related]

  • 8. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 9. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.
    Adv Med Sci; 2013 May; 58(2):353-61. PubMed ID: 24384771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biomarkers of renal function, which and when?
    Wasung ME, Chawla LS, Madero M.
    Clin Chim Acta; 2015 Jan 01; 438():350-7. PubMed ID: 25195004
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.
    Donadio C.
    Crit Care; 2014 Feb 28; 18(1):R39. PubMed ID: 24581340
    [Abstract] [Full Text] [Related]

  • 14. Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A, Hutayanon P, Piyayotai D.
    BMC Nephrol; 2013 Dec 05; 14():270. PubMed ID: 24305547
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.
    Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, Fazio MR, Nicocia G, Buemi M.
    Clin J Am Soc Nephrol; 2009 Feb 05; 4(2):337-44. PubMed ID: 19176795
    [Abstract] [Full Text] [Related]

  • 16. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP, Kastritis E, Gkotzamanidou M, Christoulas D, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Roussou M, Margeli A, Papassotiriou I, Dimopoulos MA, Terpos E.
    Clin Lymphoma Myeloma Leuk; 2016 Jan 05; 16(1):29-35. PubMed ID: 26632077
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study.
    Yang YH, He XJ, Chen SR, Wang L, Li EM, Xu LY.
    Endocrine; 2009 Aug 05; 36(1):45-51. PubMed ID: 19390997
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W, Xie Y, Wang Q, Xu W, Mou S, Ni Z.
    Nephrology (Carlton); 2014 Apr 05; 19(4):186-94. PubMed ID: 24165570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.